Results 11 to 20 of about 528,594 (306)
Melanoma [PDF]
Journal of the National Comprehensive Cancer Network, 2012 Melanoma is a relatively common neoplasm which is increasing in incidence. Melanoma appears as a variegated irregular maculopapular
lesion usually on the skin, but possibly on mucosae, conjunctiva, orbit, nails and oesophagus. They may be black,
brown, Daniel G, Coit, Robert, Andtbacka, Christopher J, Anker, Christopher K, Bichakjian, William E, Carson, Adil, Daud, Raza A, Dilawari, Dominick, Dimaio, Valerie, Guild, Allan C, Halpern, F Stephen, Hodi, Mark C, Kelley, Nikhil I, Khushalani, Ragini R, Kudchadkar, Julie R, Lange, Anne, Lind, Mary C, Martini, Anthony J, Olszanski, Scott K, Pruitt, Merrick I, Ross, Susan M, Swetter, Kenneth K, Tanabe, John A, Thompson, Vijay, Trisal, Marshall M, Urist +24 moreopenaire +4 more sourcesMelanoma [PDF]
Canadian Medical Association Journal, 2019 AbstractCurrent recommendations by the United States Preventive Services Task Force do not support screening for skin cancer. Melanoma is unique among cancers because detection is through visual inspection. Development of technologies that aid visual inspection have supported screening strategies in high‐risk populations such as older fair skinned ...Robert, Micieli, Kucy, Ponopenaire +4 more sourcesProton beam radiotherapy in the management of uveal melanoma: clinical experience in Scotland [PDF]
, 2008 <p>Aim: To evaluate proton-beam radiotherapy (PBRT) in the management of uveal melanoma in Scotland.</p>
<p>Methods: A retrospective review was undertaken on all patients receiving PBRT for uveal melanoma (1994–2005).McConnachie, A., Alex Taylor, Alex Kacperek, Aziz, S., Samir Aziz, Kemp, E., Andrzej McConnachie, Ewan Kemp, Kacperek, A., Taylor, A. +9 morecore +1 more sourceNew Advances in Melanoma [PDF]
, 2022 Melanoma is a very aggressive tumor which is derived from the transformation of pigment-producing cells termed the melanocytes. This cancer type accounts for most of the deaths associated with skin cancer as well as its incidence and is in constant ...core +2 more sourcesAssociation of MC1R Variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study [PDF]
, 2010 <p><b>Background</b> Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associated with a high risk for melanoma. Penetrance of CDKN2A mutations is modified by pigmentation characteristics, nevus phenotypes,Pastorino, L., Melanoma Genetics Consortium, Goldstein, A M, Taylor JC, Ming M, Taylor Y, Martin NG, PUIG S, Rull R, Gliori S, Holland EA., Gonzalez M, Calista, D, Mackie, R.M., Lindén D, N. K. Hayward, Randerson-Moor, J, Palou J, Vilalta A, Ming, M. E., V. Höiom, Belle, P. van, Conill C, Gillanders, E, Avril, M.F., Vidal-Sicart S, Carrera, C., Bishop, J.A.N., Lang, J. M., Bishop, D. T., Mohamdi, H., GRUIS N, Bressac-de Paillerets, B, BIANCHI-SCARRÀ G, Gruis NA, P. A. Kanetsky, Bressac-de Paillerets, B., Malvehy J, N. Gruis, Whiteman DC, CARRERA C, Hayward, N. K., Tucker, M.A., G. J. Mann, van der Velden, P, Badenas C, R. M. Mackie, Stark, M., Nasti S, Marti-Laborda R, GenoMEL, Harbst K, V. Chaudru, RANDERSON-MOOR J, B. Bressac-de Paillerets, C. Ingvar, ELDER DE, PASTORINO L, J. Randerson-Moor, Tsao, H, Mohamdi, H, Landi G, Cuellar F, HAYWARD NK, AVRIL MF, Brassac-de Paillerets, B., Minghetti P, van Belle, P., Carrera, C, C. J. Njauw, Kanetsky P, GenoMEL,, E. Gillanders, A. M. Goldstein, Calista, D., Hayward, N K, Gargiulo S, W. BRUNO, Kanetsky, P.A., Arguís P, Bianchi-Scarra, G., L. Pastorino, D. E. Elder, Bertazzi PA, BERGMAN W, Chaudru, V, Mackie, R M, HÖIOM V, Battistuzzi L, Duffy DL, Origone P, Elder, D. E., Holland, E.A., HANSSON J, MacGregor S, MANN GJ, TUCKER MA, Mack T, Lang, J.M., F. Demenais, X. R. Yang, Ancero A, de Lichy M, Newton Bishop, J. A., Bianhi-Scarrà G, Landi, MT, Leake S, Mann, G J, Landi, M.T., VAN BELLE P, Stark, M, Hayward, N.K., van Mourik L, Yang, X.R., Parossian S, Demenais, F, Nielsen K, Elder, D.E., Tsao, H., Arcangeli F, Montgomery GW, MOHAMDI H, CHAUDRU V, J. Palmer, Mackie, R., M. E. Ming, Demenais, F., AZIZI E, Ming, M E, M. T. Landi, Azizi, E., Holland, E A, Randerson-Moor, J., Alós L, Gruis, N, Olsson, Håkan, J. M. Lang, van Nieuwpport FA, Castel T, LANDI MT, LANG JM, M. F. Avril, Haynes S, Kanetsky, P. A., Queirolo P, Karpavicius B, BISHOP DT, Palmer, J., M. Harland, Hogg, D., J. Hansson, CALISTA D, VAN DER VELDEN P, van der Velden, P., Yang, X R, Chaudru, V., Bergman, W., van Belle, P, Chan M, Höiom, V, BRUNO W, Kanetsky, P A, PALMER J, NJAUW CJ, Lang, J., H. Tsao, Sánchez M, G. Bianchi-Scarrà, Vilella R, NEWTON BISHOP JA, Avril, M F, Maubec E, Goldstein, A.M., P. van der Velden, J. A. Newton Bishop, KANETSKY PA, Mila M, Hoiom, V., Melanoma Genetics Consortium: Demenais F, H. Olsson, BRESSAC-DE PAILLERETS B, Harland, M, Tuominen R, E. A. Holland, Affleck P, Whittaker L, Loo JC, Mackie, R. M., Tesema L, Njauw, C. J., Iles MM, Borg Å, Holland, E. A., Ingvar, Christian, MACKIE RM, Hansson, J., HOLLAND EA, GHIORZO P, Butille JA, Cervera R, Ogbah Z, Azizi, E, Bishop, D.T., C. Carrera, Velden, P. van der, Landi, M. T., Campo A, Ming, M.E., Newton Bishop, J A, Jeannin P, Lang, J M, Bishop, D T, MING ME, Njauw, C J, E. Azizi, HARLAND M, Lang J, M. A. Tucker, Elder D, Gabriel D, Gruis, N., Gillanders, E., W. Bergman, Lesueur F, Capirossi D, DEMENAIS F, STARK M, Mackie R, Ingvar, C., GILLANDERS E, Njauw, C.J., P. van Belle, Barrett JH, GOLDSTEIN AM, M. Stark, Hogg, D, Iglesias P, Puig, S., D. Hogg, Elder, D E, INGVAR C, Kukalizch K, Mann, G.J., Olsson, H., Bergman, W, Pastorino, L, Mann, G. J., S. Puig, Schmid H, Tucker, M A, D. Calista, Mitra N, TSAO H, YANG XR, Kefford RF, P. GHIORZO, Njauw CN, Avril, M. F., Jönsson G, Harrison J, HOGG D, Ruffin A, Aguilera P, D. T. Bishop, Corda E, OLSSON H, Puig, S, Hansson, J, Palmer, J, Bianchi-Scarrà, G, H. Mohamdi, Måsbäck A, Newton Bishop, J.A., Harland, M., Goldstein, A. M. +274 morecore +1 more sourcePAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells [PDF]
, 2011 PAX transcription factors play an important role during development and carcinogenesis. In this study, we investigated PAX2 protein levels in melanocytes and melanoma cells by Western Blot and immunofluorescence analysis and characterized the role of ...Ungerer Christopher, Hardt, Katja, Kai Doberstein, Hardt Katja, Pfeilschifter, Josef (Prof. Dr.), Lee Sophia Boyoung, Mihic-Probst Daniela, Mihic-Probst, D, Ungerer, Christopher, Mittelbronn, Michel, Mittelbronn, Michel Guy André, Bürger Claudia, Gutwein, P, Gutwein, Paul, Wolf-Henning Boehncke, Wieland, A, Sophia Boyoung Lee, Pfeilschifter, J, Josef Pfeilschifter, Baumgarten Peter, Paul Gutwein, Hardt, K, Pfeilschifter, Josef M., Michel Mittelbronn, Lee, Sophia Boyoung, Daniela Mihic-Probst, Claudia Bürger, Anja Wieland, Gutwein Paul, Wieland Anja, Baumgarten, Peter, Katja Hardt, Doberstein, K, Lee, S B, Peter Baumgarten, Baumgarten, P, Doberstein Kai, Mittelbronn Michel, Boehncke, Wolf-Henning, Ungerer, C, Doberstein, Kai, Boehncke Wolf-Henning, Wieland, Anja, Boehncke, W H, Bürger, Claudia, Bürger, C, Christopher Ungerer, Mittelbronn, M, Mihic-Probst, Daniela, Pfeilschifter Josef +49 morecore +1 more sourceSelective induction of cell death in melanoma cell lines through targeting of Mcl-1 and A1. [PDF]
, 2012 Melanoma is an often fatal form of skin cancer which is remarkably resistant against radio- and chemotherapy. Even new strategies that target RAS/RAF signaling and display unprecedented efficacy are characterized by resistance mechanisms.Berking, Carola, Senft Daniela, Robert Besch, Carola Berking, Saskia A Graf, Claudia Kammerbauer, Thomas Ruzicka, Graf, Saskia A., Besch, Robert, Graf Saskia A., Senft, Daniela, Berking Carola, Kammerbauer, Claudia, Daniela Senft, Besch Robert, Kammerbauer Claudia, Ruzicka, Thomas, Saskia A. Graf, Ruzicka Thomas +18 morecore +1 more sourcePrimary dermal melanoma in a patient with a history of multiple malignancies: a case report with molecular characterization [PDF]
, 2013 Introduction: Primary dermal melanoma (PDM) is a recently described clinical entity accounting for less than 1% of all melanomas. Histologically, it is located in the dermis or subcutaneous tissue, and it shows no connections with the overlying epidermis.Palomba, Grazia, Marcello Gulino, Sini, Germana, Maria Colombino, Maxia, Sara, Grazia Palomba, Palmieri, Giuseppe, Cossu, Antonio, Germana Sini, Paliogiannis, Panagiotis, Giuseppe Palmieri, Lissia, Amelia, Rubino, Corrado, Gulino, Marcello, Panagiotis Paliogiannis, Amelia Lissia, Antonio Cossu, Colombino, Maria, Sara Maxia, Corrado Rubino +19 morecore +1 more sourceThe Outcome of Patients with Melanoma Is Not Associated with the Time Point of Lymphatic Mapping with Respect to Excisional Biopsy of the Primary Tumor [PDF]
, 2010 Background: Sentinel lymph node biopsy (SLNB) has become the standard care for melanoma and is an important diagnostic procedure. It has been doubted whether lymphoscintigraphy detects the correct sentinel lymph node (SLN) when excision of the tumor and ...Ruzicka, T., Berking, Carola, Geimer, Till, Geimer, T., Kunte, C., Berking, C., Baumert, Jens, Schmid-Wendtner, Monika-Hildegard, Gauwerky, Katharina J., Kunte, Christian, Flaig, Michael J., Gauwerky, K.J., Baumert, J.J., Flaig, M.J., Ruzicka, Thomas, Schmid-Wendtner, M.H. +15 morecore +1 more source
